Lack of differential sensitivity to cholinesterase inhibition in fetuses and neonates compared to dams treated perinatally with chlorpyrifos

Toxicological Sciences

Volumn 53, Issue 2, 2000, Pages 438-446

  Mattsson, Joel L ^a   Maurissen, Jacques P J ^b   Nolan, Richard J ^a   Brzak, Kathy A ^b  

^a DOW AGROSCIENCES LLC   (United States)

^b DOW CHEMICAL COMPANY   (United States)

Author keywords

Blood; Chlorpyrifos; Chlorpyrifos oxon; Cholinesterase; Dams; Dursban ; Fetuses; Milk; Pups; Rats; Trichloropyridinol

Indexed keywords

CHLORPYRIFOS; CHOLINESTERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CONTROLLED STUDY; ENZYME INHIBITION; FETUS; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; MILK; NEWBORN; NONHUMAN; PERINATAL PERIOD; RAT;

EID: 0033953262     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/53.2.438     Document Type: Article

References (33)

1. Atterberry, T. T., Burnett, W. T., and Chambers, J. E. (1997). Age-related differences in parathion and chlorpyrifos toxicity in male rats: Target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism. Toxicol. Appl. Pharmacol. 147, 411-418.
2. Breslin, W. J., Liberacki, A. B., Dittenber, D. A., and Quast, J. F. (1996). Evaluation of the developmental and reproductive toxicity of chlorpyrifos in the rat. Fundam. Appl. Toxicol. 29, 119-130.
3. Brzak, K. A., Harms, D. W., Bartels, M. J., and Nolan, R. I. (1998). Determination of chlorpyrifos, chlorpyrifos oxon, and 3,5,6-trichloro-2-pyridinol in rat and human blood. J. Anal. Toxicol. 22, 203-210.
4. Byczkowski, J. Z., Kinkead, E. R., Leahy, H., Randall, G. M., and Fisher, J. W. (1994). Computer simulation of the lactational transfer of tetrachloroethylene in rats, using a physiologically based model. Toxicol. Appl. Pharmacol. 125, 228-236.
5. Campbell, C. G., Seidler, F. J., and Slotkin, T. A. (1997). Chlorpyrifos interferes with cell development in rat brain regions. Brain Res. Bull. 43, 179-189.
6. CFR (Code of Federal Regulations) (1985). Title 9: Animals and Animal Products, Subchapter A: Animal Welfare. Office of the Federal Register, Washington, DC.
7. Chanda, S. M., Harp, P., Liu, J., and Pope, C. N. (1995). Comparative developmental and maternal neurotoxicity following acute gestational exposure to chlorpyrifos in rats. J. Toxicol. Environ. Health 44, 189-202.
8. Chanda, S. M., and Pope, C. N. (1996). Neurochemical and neurobehavioral effects of repeated gestational exposure to chlorpyrifos in maternal and developing rats. Pharmacol. Biochem. Behav. 53(4), 771-776.
9. Fisher, J. W., Whittaker, T. A., Taylor, D. H., Clewell, H. J. III, and Andersen, M. E. (1990). Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 102, 497-513.
10. Gibson, J. E., Chen, W. L., and Peterson, R. K. D. (1999). How to determine if an additional 10X safety factor is needed for chemicals: A case study with chlorpyrifos. Toxicol. Sci. 48, 117-122.
11. Herrera, E., Lasuncion, M. A., Gomez-Coronado, D., Aranda, P., Lopez-Luna, P., and Maier, I. (1988). Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am. J. Obstet. Gynecol. 158(6 Pt 2), 1575-1583.
12. Herrera, E., Munoz, C., Lopez-Luna, P., and Ramos, P. (1994). Carbohydrate-lipid metabolism during gestation and their control by insulin. Braz. J. Med. Biol. Res. 27, 2499-2519.
13. Hoberman, A. M. (1998). Developmental neurotoxicity study of chlorpyrifos administered orally via gavage to Crl: CD®BR VAF/Plus® presumed pregnant rats. Report of the Dow Chemical Company, Midland, MI.
14. Hunter, D. L., Marshall, R. S., and Padilla, S. (1997). Automated instrument analysis of cholinesterase activity in tissues from carbamate-treated animals: A cautionary note. Toxicol. Methods 7, 43-53.
15. Lassiter, T. L., Padilla, S., Mortensen, S. R., Chanda, S. M., Moser, V. C., and Barone, S., Jr. (1998). Gestational exposure to chlorpyrifos: Apparent protection of the fetus? Toxicol. Appl. Pharmacol. 152, 56-65.
16. Loebstein, R., Lalkin, A., and Koren, G. (1997). Pharmacokinetic changes during pregnancy and their clinical relevance. Clin. Pharmacokinet. 33, 328-343.
17. Maurissen, J. P. J., Hoberman, A. M., Garman, R. H., and Hanley, T. R., Jr. (1999). Lack of developmental neurotoxicity in rat pups from dams treated by gavage with chlorpyrifos. (Submitted to Toxicol. Sci.).
18. Mortensen, S. R., Chanda, S. M., Hooper, M. J., and Padilla, S. (1996). Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos. J. Biochem. Toxicol. 11, 279-287.
19. Moser, V. C., Chanda, S. M., Mortensen, S. R., and Padilla, S. (1998). Age-and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol. Sci. 46, 211-222.
20. Moser, V. C., and Padilla, S. with the technical assistance of Hunter, D. L., Marshall, R. S., McDaniel, K. L., and Phillips, P. M. (1998). Age-and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol. Appl. Pharmacol. 149, 107-119.
21. Nicholas, K. R., and Hartman, P. E. (1991). Milk secretion in the rat: Progressive changes in milk composition during lactation and weaning and the effect of diet. Comp. Biochem. Physiol. 98A, 535-542.
22. NRC (National Research Council) (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
23. Pope, C. N., and Chakraborti, T. K. (1992). Dose-related inhibition of brain and plasma cholinesterase in neonatal and adult rats following sublethal organophosphate exposures. Toxicology 73, 35-43.
24. Pope, C. N., Chakraborti, T. K., Chapman, M. L., Farrer, J. D., and Arthun, D. (1991). Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology 68, 51-61.
25. Pope, C. N., and Liu, J. (1997). Age-related differences in sensitivity to organophosphate pesticides. Environ. Toxicol. Pharmacol. 4, 309-314.
26. Sampson, D. A., and Jansen, G. R. (1984). Measurement of milk yield in the lactating rat from pup weight and weight gain. J. Pediat. Gastroenterol. Nutr. 3(4), 613-617.
27. Schardein, J. L., and Scialli, A. R. (1999). The legislation of toxicologic safety factors: The Food Quality Protection Act with chlorpyrifos as a test case. Reprod. Toxicol. 13, 1-14.
28. 3H]oxo-tremorine binding in neonatal and adult rat heart following repeated oral chlorpyrifos exposures. The Toxicologist 48(S 1), 100.
29. Sultatos, L. G., Shao, M., and Murphy, S. D. (1984). The role of hepatic biotransformation in mediating the acute toxicity of the phosphorothionate insecticide chlorpyrifos. Toxicol. Appl. Pharmacol. 73, 60-68.
30. U.S. EPA (1989). United States Environmental Protection Agency. Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); Good Laboratory Practice Standards; Final Rule. 40 CFR, Part 160, 1989.
31. U.S. EPA (1991). United States Environmental Protection Agency. Pesticide Assessment Guidelines. Subdivision F - Hazard Evaluation: Human and Domestic Animals, Addendum 10, Neurotoxicity. Health Effects Division, Office of Pesticide Programs, March, 1991.
32. Whitney, K. D., Seidler, F. J., and Slotkin, T. A. (1995). Developmental neurotoxicity of chlorpyrifos: Cellular mechanisms. Toxicol. Appl. Pharmacol. 134, 53-62.
33. Zheng, Q., Olivier, K., Won, Y., and Pope, C. (1999). Abstract 874. Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in neonatal and adult rats. The Toxicologist 48(S 1), 186.